AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Therapeutic Recommendations for Nephroblastoma

Recruitingn/aAges 6 Months - 18 YearsAllFrench Africa Pediatric Oncology Group
💬

In plain words

What the trial is, and whether it could suit you

The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: Unilateral Nephroblastoma Tumor Not previously treated The general health of the child will permit treatment. . Exclusion Criteria: Bilateral Nephroblastoma tumor Previously treated Disease too advanced Doubt concerning the diagnosis Treatment Refusal
💊

What it tests

  • Data collection
📍

Where

7 sites
Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle
Ouagadougou, Burkina Faso
CHU de Treichville à ABIDJAN
Abidjan, Côte d’Ivoire
CUK (Cliniques Universitaires de Kinshasa)
Kinshasa, Democratic Republic of the Congo
Cliniques Universitaires de Lubumbashi (CUL)
Lubumbashi, Democratic Republic of the Congo
HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona
Antananarivo, Madagascar
CHU Gabriel Touré (HGT)
Bamako, Mali
Hôpital Aristide Le Dantec, Avenue Pasteur, BP 3001
Dakar, Senegal
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy